Comparison of Characteristics of Future Myocardial Infarctions in Women With Baseline High Versus Baseline Low Levels of High-Sensitivity C-Reactive Protein

American Journal of Cardiology

Volumn 99, Issue 11, 2007, Pages 1500-1503

  Bansal, Sandeep ^a   Ridker, Paul M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ARTERIOGRAPHY; ARTICLE; BODY MASS; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE COURSE; ELECTROCARDIOGRAM; ENZYME BLOOD LEVEL; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; ST SEGMENT ELEVATION; STATISTICAL MODEL;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHOLESTEROL, HDL; CORONARY STENOSIS; CREATINE KINASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RESEARCH DESIGN; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; TRIGLYCERIDES; TROPONIN;

EID: 34248677593     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.01.022     Document Type: Article

References (24)

1. Ridker P.M., Cushman M., Stampfer M.J., Tracy R.P., and Hennekens C.H. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336 (1997) 973-979
2. Ridker P.M., Hennekens C.H., Buring J.E., and Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342 (2000) 836-843
3. Tracy R.P., Lemaitre R.N., Psaty B.M., Ives D.G., Evans R.W., Cushman M., Meilahn E.N., and Kuller L.H. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol 17 (1997) 1121-1127
4. Koenig W., Sund M., Frohlich M., Fischer H.G., Lowel H., Doring A., Hutchinson W.L., and Pepys M.B. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 99 (1999) 237-242
5. Danesh J., Whincup P., Walker M., Lennon L., Thomson A., Appleby P., Gallimore J.R., and Pepys M.B. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ 321 (2000) 199-204
6. Cushman M., Arnold A.M., Psaty B.M., Manolio T.A., Kuller L.H., Burke G.L., Polak J.F., and Tracy R.P. C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: the cardiovascular health study. Circulation 112 (2005) 25-31
7. van Dijk E.J., Prins N.D., Vermeer S.E., Vrooman H.A., Hofman A., Koudstaal P.J., and Breteler M.M. C-reactive protein and cerebral small-vessel disease: the Rotterdam Scan Study. Circulation 112 (2005) 900-905
8. Schillinger M., Exner M., Mlekusch W., Sabeti S., Amighi J., Nikowitsch R., Timmel E., Kickinger B., Minar C., Pones M., et al. Inflammation and Carotid Artery-Risk for Atherosclerosis Study (ICARAS). Circulation 111 (2005) 2203-2209
9. Ishikawa T., Hatakeyama K., Imamura T., Date H., Shibata Y., Hikichi Y., Asada Y., and Eto T. Involvement of C-reactive protein obtained by directional coronary atherectomy in plaque instability and developing restenosis in patients with stable or unstable angina pectoris. Am J Cardiol 91 (2003) 287-292
10. Berk B.C., Weintraub W.S., and Alexander R.W. Elevation of C-reactive protein in "active" coronary artery disease. Am J Cardiol 65 (1990) 168-172
11. Buring J.E., and Hennekens C.H. The Women's Health Study: summary of the study design. J Myocardial Ischemia 4 (1992) 27-29
12. Ridker P.M., Cook N.R., Lee I.M., Gordon D., Gaziano J.M., Manson J.E., Hennekens C.H., and Buring J.E. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 352 (2005) 1293-1304
13. Lee I.M., Cook N.R., Gaziano J.M., Gordon D., Ridker P.M., Manson J.E., Hennekens C.H., and Buring J.E. Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial. JAMA 294 (2005) 56-65
14. Han T.S., Sattar N., Williams K., Gonzalez-Villalpando C., Lean M.E., and Haffner S.M. Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study. Diabetes Care 25 (2002) 2016-2021
15. Hainline A., Karon J., and Lippel K. Manual of Laboratory Operations: Lipid Research Clinics Program and Lipid and Lipoprotein Analysis (1982), Department of Health and Human Services, Bethesda, MD
16. Ridker P.M., Rifai N., Rose L., Buring J.E., and Cook N.R. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 347 (2002) 1557-1565
17. Redberg R.F., Rifai N., Gee L., and Ridker P.M. Lack of association of C-reactive protein and coronary calcium by electron beam computed tomography in postmenopausal women: implications for coronary artery disease screening. J Am Coll Cardiol 36 (2000) 39-43
18. Hunt M.E., O'Malley P.G., Vernalis M.N., Feuerstein I.M., and Taylor A.J. C-reactive protein is not associated with the presence or extent of calcified subclinical atherosclerosis. Am Heart J 141 (2001) 206-210
19. Wang T.J., Larson M.G., Levy D., Benjamin E.J., Kupka M.J., Manning W.J., Clouse M.E., D'Agostino R.B., Wilson P.W., and O'Donnell C.J. C-reactive protein is associated with subclinical epicardial coronary calcification in men and women: the Framingham Heart Study. Circulation 106 (2002) 1189-1191
20. Wang T.J., Nam B.H., Wilson P.W., Wolf P.A., Levy D., Polak J.F., D'Agostino R.B., and O'Donnell C.J. Association of C-reactive protein with carotid atherosclerosis in men and women: the Framingham Heart Study. Arterioscler Thromb Vasc Biol 22 (2002) 1662-1667
21. Park R., Detrano R., Xiang M., Fu P., Ibrahim Y., LaBree L., and Azen S. Combined use of computed tomography coronary calcium scores and C-reactive protein levels in predicting cardiovascular events in nondiabetic individuals. Circulation 106 (2002) 2073-2077
22. Khera A., de Lemos J.A., Peshock R.M., Lo H.S., Stanek H.G., Murphy S.A., Wians Jr. F.H., Grundy S.M., and McGuire D.K. Relationship between C-reactive protein and subclinical atherosclerosis: the Dallas Heart Study. Circulation 113 (2006) 38-43
23. Mendall M.A., Strachan D.P., Butland B.K., Ballam L., Morris J., Sweetnam P.M., and Elwood P.C. C-reactive protein: relation to total mortality, cardiovascular mortality and cardiovascular risk factors in men. Eur Heart J 21 (2000) 1584-1590
24. Ockene I.S., Matthews C.E., Rifai N., Ridker P.M., Reed G., and Stanek E. Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adults. Clin Chem 47 (2001) 444-450